Searched for
SYMBICORT
Cipla targets $1 bn US revenue in FY27Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics ...25 Jul, 2025, 10.29 PM IST- Cipla faces revenue and margin pressure ahead of Revlimid patent expiryCipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst downgrades. Mar...04 Jul, 2025, 06.11 AM IST
- Go on, pop the innovation pill: ₹5,000 cr push signals India’s shift from copy to createIndia's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr PRIP scheme a...24 Jun, 2025, 12.25 AM IST
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...20 Feb, 2025, 06.11 PM IST
- Cipla Q3 preview: Up to 7% YoY uptick seen in revenue. Margins to fall on a YoY and sequential basisCipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth. Brokerages have differi...27 Jan, 2025, 11.19 AM IST
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...03 Dec, 2024, 04.06 PM IST
- Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaMankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh st...16 Jul, 2024, 05.09 PM IST
- Be bullish, just manage risks & desire; 5 midcap stocks for long term investorsIn a bullish market many things change and one of them is the relationship between opportunity and challenges. Given the way markets are pa...14 Jul, 2024, 03.53 PM IST
- Mankind Pharma scouts for M&A deals to boost local branded bizMankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...06 Jun, 2024, 11.59 PM IST
- Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in IndiaAstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca w...11 Mar, 2024, 05.39 PM IST
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...23 Feb, 2024, 03.29 PM IST
- For calibrating and diversifying risks? 6 midcap stocks from different sectors with the right financial matrixAs the Dalal street continues to be in party mode, staying bullish would appear to be the most logical thing at this point of time. Why fig...13 Jan, 2024, 02.37 PM IST
- AstraZeneca starts to make modest profit from Covid-19 vaccineThe Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...12 Nov, 2021, 06.45 PM IST
- Fifteen stocks in focus on Wednesday, 21 June 2017Adani Ports plans to raise at least $500 million through overseas bond sales.21 Jun, 2017, 08.30 AM IST
- AstraZeneca gets marketing nod for asthma drug SymbicortResults from AstraZeneca's two clinical studies have shown that the addition of formoterol to budesonide improved asthma symptoms and lung ...20 Jun, 2017, 07.10 PM IST
- FDA approves Merck's new lung drug DuleraMerck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...24 Jun, 2010, 06.47 PM IST
- AstraZeneca first-quarter profit up 42 pcAstraZeneca posted a 42 per cent rise in first quarter net profit on Thursday, boosted by sales of its heart drug Toprol-XL in the United S...30 Apr, 2009, 09.57 PM IST
Load More
